Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medmix AG's Enterprise Value is $712.8 Mil.
Medmix AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $24.4 Mil. Therefore, Medmix AG's EV-to-EBIT ratio for today is 29.25.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Medmix AG's Enterprise Value is $712.8 Mil.
Medmix AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $93.4 Mil. Therefore, Medmix AG's EV-to-EBITDA ratio for today is 7.63.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Medmix AG's Enterprise Value is $712.8 Mil.
Medmix AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $556.5 Mil. Therefore, Medmix AG's EV-to-Revenue ratio for today is 1.28.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Medmix AG's Enterprise Value is $712.8 Mil.
Medmix AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $33.2 Mil. Therefore, Medmix AG's EV-to-FCF ratio for today is 21.46.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Medmix AG (OTCPK:MDMXF) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Medmix AG's current Enterprise Value is $712.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $24.4 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Medmix AG's current Enterprise Value is $712.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $93.4 Mil.
Medmix AG's current Enterprise Value is $712.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $556.5 Mil.
Medmix AG's current Enterprise Value is $712.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was $84.3 Mil.
Medmix AG's current Enterprise Value is $712.8 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Medmix AG's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was $33.2 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG Enterprise Value Related Terms
Medmix AG Enterprise Value Historical Data
* Premium members only.
The historical data trend for Medmix AG's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MDMXF vs GEV, ETN, PH: Enterprise Value Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Enterprise Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Medmix AG's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Medmix AG's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (MDMXF) has a Enterprise Value of $712.8 Mil as of Jul. 12, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medmix AG and its competitors.
Is Medmix AG's Enterprise Value too high?
Medmix AG's current Enterprise Value is $712.8 Mil. Overall, Medmix AG has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Enterprise Value compare to GEV and ETN?
Medmix AG's Enterprise Value of $712.8 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for an Industrial Products company?
A good Enterprise Value depends on the Industrial Products industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Medmix AG and its competitors. Medmix AG's current Enterprise Value is $712.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Medmix AG (MDMXF) has a current Enterprise Value of $712.8 Mil. The stock's GF Value™ is $26.13, compared to a current price of $17.40 — trading 33.4% below its estimated fair value. The current Enterprise Value is $712.8 Mil. Medmix AG's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Medmix AG (MDMXF), the current Enterprise Value is $712.8 Mil as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (MDMXF) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of $17.40 is trading 33.4% below its estimated GF Value™ of $26.13.
Key valuation signals for MDMXF:
Enterprise Value: $712.8 Mil
GF Value™: $26.13 vs. price of $17.40 (33.4% below fair value)
No single metric tells the full story. See the MDMXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
61GF Score
Get the complete analysis for MDMXF
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MDMXF has been successfully added to your 
